About-cancer / kurapwa / zvinodhaka / myeloproliferative-neoplasms

Zvinodhaka Zvinotenderwa zveMyeloproliferative Neoplasms

Iri peji rinonyora kenza zvinodhaka zvinogamuchirwa neKudya uye Dhiraimendi Administration (FDA) ye myeloproliferative neoplasms Rondedzero yacho inosanganisira mazita akajairika uye emhando Iri peji rinonyorawo zvakajairika zvinodhaka zvinosanganiswa zvinoshandiswa mu myeloproliferative neoplasms. Iyo yega mishonga iri mubatanidzwa ndeye FDA-inogamuchirwa. Zvisinei, kusanganiswa kwezvinodhaka ivo pachavo kazhinji hakugamuchirwe, asi kunoshandiswa zvakanyanya.

Mazita emishonga anonongedzera kuNCI's Cancer Drug Information pfupiso. Panogona kuve nemishonga inoshandiswa mune myeloproliferative neoplasms isina kunyorwa pano.

Zvinodhaka Zvinotenderwa zveMyeloproliferative Neoplasms

Adriamycin PFS (Doxorubicin Hydrochloride)

Adriamycin RDF (Doxorubicin Hydrochloride)

Arsenic Trioxide

Azacitidine

Cerubidine (Daunorubicin Hydrochloride)

Clafen (Cyclophosphamide)

Cyclophosphamide

Cytarabine

Cytosar-U (Cytarabine)

Cytoxan (Cyclophosphamide)

Dacogen (Decitabine)

Dasatinib

Daunorubicin Hydrochloride

Decitabine

Doxorubicin Hydrochloride

Fedratinib Hydrochloride

Gleevec (Imatinib Mesylate)

Imatinib Mesylate

Inrebic (Fedratinib Hydrochloride)

Jakafi (Ruxolitinib Phosphate)

Nilotinib

Rubidomycin (Daunorubicin Hydrochloride)

Ruxolitinib Phosphate

Kuende (KUE)

Tarabine PFS (Cytarabine)

Zimbabwe (Nilotinib)

Trisenox (Arsenic Trioxide)

Vidaza (Azacitidine)

Zvinodhaka Zvinosanganiswa Zvinoshandiswa muMyeloproliferative Neoplasms

ADE